Active Ingredient(s): Levobetaxolol
FDA Approved: * February 23, 2000
Pharm Company: * ALCON
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Betaxon Overview

Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma. It is marketed as a 0.25 or 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker). Contents 1 Indications 2 Effect 3 Contraindications and side effects 4 History 5 References Indications It is indicated for intraocular pressure reduction in patients with open-angle glaucoma or ocular...

Read more Betaxon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Betaxon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Suspension: 0.5%
  • Suspension/drops: 0.5%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Levobetaxolol or a similar ingredient: (1 result)